News

2020-02-27	ContextVision Grows Medical Imaging Market Footprint With New Global Customers
2020-02-20	ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors
2019-12-18	ContextVision’s CEO Fredrik Palm discuss innovation around AI-powered diagnostic imaging and digital pathology at Sweden Korea Business Summit

2020-02-27	ContextVision Grows Medical Imaging Market Footprint With New Global Customers
2020-02-20	ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors
2019-12-18	ContextVision’s CEO Fredrik Palm discuss innovation around AI-powered diagnostic imaging and digital pathology at Sweden Korea Business Summit

Upcoming events

2020-01-14 Join us at ECR 2020, March 11–14, Vienna
2019-11-07 Welcome to RSNA 2019, the 105th Scientific Assembly and Annual Meeting, December 1–5
2019-10-04 Meet us at CMEF Autumn 2019

2020-01-14 Join us at ECR 2020, March 11–14, Vienna
2019-11-07 Welcome to RSNA 2019, the 105th Scientific Assembly and Annual Meeting, December 1–5
2019-10-04 Meet us at CMEF Autumn 2019

2019-12-06	ContextVision debuts ultrasound image enhancement product
2019-11-18	ContextVision to unveil Rivent US software at RSNA 2019
2019-03-18	Lovende svar i ContextVision studie - appearance in the Norwegian business newspaper Finansavisen

2019-12-06	ContextVision debuts ultrasound image enhancement product
2019-11-18	ContextVision to unveil Rivent US software at RSNA 2019
2019-03-18	Lovende svar i ContextVision studie - appearance in the Norwegian business newspaper Finansavisen

ContextVision Company Presentation (pdf)

Ultrasound Product Brochure (pdf)

Digital Radiography Product Brochure (pdf)

Mammography Product Brochure (pdf)

MRI Product Brochure (pdf)

For press information and/or inquiries, please contact

Fredrik Palm, CEO

E-mail:

ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. As the global market leader within image enhancement, ContextVision is a software partner to leading medical imaging manufacturers around the world. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
As an industry pioneer for more than 30 years, ContextVision has developed state-of-the-art capabilities in the latest artificial intelligence technologies. By combining these with its well-established GOP technology, the company is introducing a new generation of image enhancement products. ContextVision is also approaching the growing digital pathology market with new AI-based decision support tools for pathologists.
The company is based in Sweden, with local representation in the U.S., Russia, Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker COV.